Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

BACKGROUND: We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). METHODS: We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute of Emory University from 2015 to 2018. Using stepwise var...

詳細記述

保存先:
書誌詳細
出版年:Cancer Med
主要な著者: Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Ravindranathan, Deepak, Brown, Jacqueline, Hitron, Emilie E., Russler, Greta A., Caulfield, Sarah, Kissick, Haydn, Alemozaffar, Mehrdad, Ogan, Kenneth, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., Bilen, Mehmet A.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2020
主題:
Clinical Cancer Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163104/
https://ncbi.nlm.nih.gov/pubmed/32100417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2932
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料